April 27, 2017 / 8:57 PM / 4 months ago

BRIEF-Biomarin says Brineura U.S. annual price $486,000

April 27 (Reuters) - Biomarin Pharmaceutical Inc

* Biomarin Pharmaceuticals says expects to begin shipping just approved Brineura within 6 weeks

* Biomarin says expected annual cost for Brineura to be $486,000 for ultra-rare pediatric brain disease

* Biomarin says will have co-pay program to assist with out-of-pocket cost of brineura Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below